445 related articles for article (PubMed ID: 37010807)
1. Inflammasome-Mediated Neuronal-Microglial Crosstalk: a Therapeutic Substrate for the Familial C9orf72 Variant of Frontotemporal Dementia/Amyotrophic Lateral Sclerosis.
Trageser KJ; Yang EJ; Smith C; Iban-Arias R; Oguchi T; Sebastian-Valverde M; Iqbal UH; Wu H; Estill M; Al Rahim M; Raval U; Herman FJ; Zhang YJ; Petrucelli L; Pasinetti GM
Mol Neurobiol; 2023 Jul; 60(7):4004-4016. PubMed ID: 37010807
[TBL] [Abstract][Full Text] [Related]
2. Negative regulation of TREM2-mediated C9orf72 poly-GA clearance by the NLRP3 inflammasome.
Shu X; Wei C; Tu WY; Zhong K; Qi S; Wang A; Bai L; Zhang SX; Luo B; Xu ZZ; Zhang K; Shen C
Cell Rep; 2023 Feb; 42(2):112133. PubMed ID: 36800288
[TBL] [Abstract][Full Text] [Related]
3. C9orf72 ALS-FTD: recent evidence for dysregulation of the autophagy-lysosome pathway at multiple levels.
Beckers J; Tharkeshwar AK; Van Damme P
Autophagy; 2021 Nov; 17(11):3306-3322. PubMed ID: 33632058
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of Immune Activation by
Trageser KJ; Smith C; Herman FJ; Ono K; Pasinetti GM
Front Neurosci; 2019; 13():1298. PubMed ID: 31920478
[TBL] [Abstract][Full Text] [Related]
5. Senataxin helicase, the causal gene defect in ALS4, is a significant modifier of C9orf72 ALS G4C2 and arginine-containing dipeptide repeat toxicity.
Bennett CL; Dastidar S; Arnold FJ; McKinstry SU; Stockford C; Freibaum BD; Sopher BL; Wu M; Seidner G; Joiner W; Taylor JP; West RJH; La Spada AR
Acta Neuropathol Commun; 2023 Oct; 11(1):164. PubMed ID: 37845749
[TBL] [Abstract][Full Text] [Related]
6. DDX3X overexpression decreases dipeptide repeat proteins in a mouse model of C9ORF72-ALS/FTD.
Fu X; Zhang Z; Hayes LR; Wright N; Asbury J; Li S; Ye Y; Sun S
Exp Neurol; 2024 Jun; 376():114768. PubMed ID: 38556190
[TBL] [Abstract][Full Text] [Related]
7. Dipeptide repeat proteins inhibit homology-directed DNA double strand break repair in C9ORF72 ALS/FTD.
Andrade NS; Ramic M; Esanov R; Liu W; Rybin MJ; Gaidosh G; Abdallah A; Del'Olio S; Huff TC; Chee NT; Anatha S; Gendron TF; Wahlestedt C; Zhang Y; Benatar M; Mueller C; Zeier Z
Mol Neurodegener; 2020 Feb; 15(1):13. PubMed ID: 32093728
[TBL] [Abstract][Full Text] [Related]
8. Arginine-rich dipeptide-repeat proteins as phase disruptors in C9-ALS/FTD.
Odeh HM; Shorter J
Emerg Top Life Sci; 2020 Dec; 4(3):293-305. PubMed ID: 32639008
[TBL] [Abstract][Full Text] [Related]
9. Stable transgenic C9orf72 zebrafish model key aspects of the ALS/FTD phenotype and reveal novel pathological features.
Shaw MP; Higginbottom A; McGown A; Castelli LM; James E; Hautbergue GM; Shaw PJ; Ramesh TM
Acta Neuropathol Commun; 2018 Nov; 6(1):125. PubMed ID: 30454072
[TBL] [Abstract][Full Text] [Related]
10. Human C9ORF72 Hexanucleotide Expansion Reproduces RNA Foci and Dipeptide Repeat Proteins but Not Neurodegeneration in BAC Transgenic Mice.
Peters OM; Cabrera GT; Tran H; Gendron TF; McKeon JE; Metterville J; Weiss A; Wightman N; Salameh J; Kim J; Sun H; Boylan KB; Dickson D; Kennedy Z; Lin Z; Zhang YJ; Daughrity L; Jung C; Gao FB; Sapp PC; Horvitz HR; Bosco DA; Brown SP; de Jong P; Petrucelli L; Mueller C; Brown RH
Neuron; 2015 Dec; 88(5):902-909. PubMed ID: 26637797
[TBL] [Abstract][Full Text] [Related]
11. BET bromodomain inhibitors PFI-1 and JQ1 are identified in an epigenetic compound screen to enhance C9ORF72 gene expression and shown to ameliorate C9ORF72-associated pathological and behavioral abnormalities in a C9ALS/FTD model.
Quezada E; Cappelli C; Diaz I; Jury N; Wightman N; Brown RH; Montecino M; van Zundert B
Clin Epigenetics; 2021 Mar; 13(1):56. PubMed ID: 33726839
[TBL] [Abstract][Full Text] [Related]
12. How villains are made: The translation of dipeptide repeat proteins in C9ORF72-ALS/FTD.
Van't Spijker HM; Almeida S
Gene; 2023 Mar; 858():147167. PubMed ID: 36621656
[TBL] [Abstract][Full Text] [Related]
13. The role of inflammation in neurodegeneration: novel insights into the role of the immune system in C9orf72 HRE-mediated ALS/FTD.
Masrori P; Beckers J; Gossye H; Van Damme P
Mol Neurodegener; 2022 Mar; 17(1):22. PubMed ID: 35303907
[TBL] [Abstract][Full Text] [Related]
14. Sense-encoded poly-GR dipeptide repeat proteins correlate to neurodegeneration and uniquely co-localize with TDP-43 in dendrites of repeat-expanded C9orf72 amyotrophic lateral sclerosis.
Saberi S; Stauffer JE; Jiang J; Garcia SD; Taylor AE; Schulte D; Ohkubo T; Schloffman CL; Maldonado M; Baughn M; Rodriguez MJ; Pizzo D; Cleveland D; Ravits J
Acta Neuropathol; 2018 Mar; 135(3):459-474. PubMed ID: 29196813
[TBL] [Abstract][Full Text] [Related]
15. Molecular Mechanisms of Neurodegeneration Related to
Babić Leko M; Župunski V; Kirincich J; Smilović D; Hortobágyi T; Hof PR; Šimić G
Behav Neurol; 2019; 2019():2909168. PubMed ID: 30774737
[TBL] [Abstract][Full Text] [Related]
16. The DNA damage response (DDR) is induced by the C9orf72 repeat expansion in amyotrophic lateral sclerosis.
Farg MA; Konopka A; Soo KY; Ito D; Atkin JD
Hum Mol Genet; 2017 Aug; 26(15):2882-2896. PubMed ID: 28481984
[TBL] [Abstract][Full Text] [Related]
17. Chimeric Peptide Species Contribute to Divergent Dipeptide Repeat Pathology in c9ALS/FTD and SCA36.
McEachin ZT; Gendron TF; Raj N; García-Murias M; Banerjee A; Purcell RH; Ward PJ; Todd TW; Merritt-Garza ME; Jansen-West K; Hales CM; García-Sobrino T; Quintáns B; Holler CJ; Taylor G; San Millán B; Teijeira S; Yamashita T; Ohkubo R; Boulis NM; Xu C; Wen Z; Streichenberger N; ; Fogel BL; Kukar T; Abe K; Dickson DW; Arias M; Glass JD; Jiang J; Tansey MG; Sobrido MJ; Petrucelli L; Rossoll W; Bassell GJ
Neuron; 2020 Jul; 107(2):292-305.e6. PubMed ID: 32375063
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic reduction of GGGGCC repeat RNA levels by hnRNPA3 suppresses neurodegeneration in Drosophila models of C9orf72-linked ALS/FTD.
Taminato T; Takeuchi T; Ueyama M; Mori K; Ikeda M; Mochizuki H; Nagai Y
Hum Mol Genet; 2023 May; 32(10):1673-1682. PubMed ID: 36611007
[TBL] [Abstract][Full Text] [Related]
19. C9-ALS-Associated Proline-Arginine Dipeptide Repeat Protein Induces Activation of NLRP3 Inflammasome of HMC3 Microglia Cells by Binding of Complement Component 1 Q Subcomponent-Binding Protein (C1QBP), and Syringin Prevents This Effect.
Fu RH; Tsai CW; Chiu SC; Liu SP; Chiang YT; Kuo YH; Shyu WC; Lin SZ
Cells; 2022 Oct; 11(19):. PubMed ID: 36231090
[TBL] [Abstract][Full Text] [Related]
20. [Impact of C9orf72 on Japanese Patients with Amytrophic Lateral Sclerosis (ALS)/Frontotemporal Dementia (FTD)].
Tomiyama H
Brain Nerve; 2019 Nov; 71(11):1190-1208. PubMed ID: 31722305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
